Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Language
Publication year range
1.
Emerg Infect Dis ; 18(1): 102-4, 2012 Jan.
Article in English | MEDLINE | ID: mdl-22257488

ABSTRACT

We report a case of type F botulism in a patient with bilateral but asymmetric neurologic deficits. Cranial nerve demyelination was found during autopsy. Bilateral, asymmetric clinical signs, although rare, do not rule out botulism. Demyelination of cranial nerves might be underrecognized during autopsy of botulism patients.


Subject(s)
Botulinum Antitoxin/therapeutic use , Botulinum Toxins/blood , Botulism/pathology , Cranial Nerves/pathology , Demyelinating Diseases/pathology , Aged , Botulism/blood , Botulism/rehabilitation , Botulism/therapy , Humans , Male
2.
Am J Infect Control ; 37(9): 723-8, 2009 Nov.
Article in English | MEDLINE | ID: mdl-19501935

ABSTRACT

BACKGROUND: In 2004, a 650-bed, tertiary care medical center experienced an outbreak of multiple antibiotic-resistant Klebsiella pneumoniae (MR-KP) that included extended-spectrum beta-lactamase (ESBL)-producing and non-ESBL-producing strains. METHODS: Characteristics associated with MR-KP were evaluated by case-control study with variables tested by conditional regression analyses. Pulsed-field gel electrophoresis (PFGE) was used to compare the molecular relatedness of isolates. RESULTS: In 2004, the incidence rate of MR-KP increased significantly compared with 2003 (relative risk [RR], 5.1; 95% confidence interval [CI]: 3.10-8.37) when only ESBL-producing K pneumoniae were present. The increase involved both ESBL-producing MR-KP and MR-KP in which ESBL production was not detected by the testing in use. Nineteen isolates were identical or closely related by PFGE. Characteristics associated with MR-KP were longer length of hospital stay (odds ratio [OR], 2.92; 95% CI: 1.17-7.30; P = .022), greater total antibiotic-days (OR, 2.81; 95% CI: 1.19-6.65; P = .018], and higher Acute Physiology and Chronic Health Evaluation (APACHE) II score (OR, 1.15; 95% CI: 1.06-1.25; P = .001). When the MR-KP cases were subdivided into ESBL-producing K pneumoniae and ESBL-negative K pneumoniae, while controlling for length of stay, total antibiotic-days was significantly associated with ESBL-producing K pneumoniae (OR, 3.8; 95% CI: 1.2-12.1; P = .02). CONCLUSION: Compared with patients housed on the same unit at the same time, patients with MR-KP had a longer length of stay and greater antibiotic exposure. Patients with longer length of stay and greater total antibiotic exposure should be potential targets for stringent infection control measures.


Subject(s)
Anti-Bacterial Agents/pharmacology , Cross Infection/epidemiology , Disease Outbreaks , Drug Resistance, Multiple, Bacterial , Klebsiella Infections/epidemiology , Klebsiella pneumoniae/drug effects , Adolescent , Adult , Aged , Aged, 80 and over , Anti-Bacterial Agents/therapeutic use , Bacterial Typing Techniques , Case-Control Studies , Child , Cluster Analysis , Cross Infection/microbiology , DNA Fingerprinting , Electrophoresis, Gel, Pulsed-Field , Female , Genotype , Hospitals , Humans , Klebsiella Infections/microbiology , Klebsiella pneumoniae/classification , Klebsiella pneumoniae/genetics , Klebsiella pneumoniae/isolation & purification , Length of Stay , Male , Middle Aged , Young Adult
3.
Vector Borne Zoonotic Dis ; 6(4): 388-94, 2006.
Article in English | MEDLINE | ID: mdl-17187574

ABSTRACT

Human granulocytic anaplasmosis (HGA) is a potentially fatal tick-borne infection caused by Anaplasma phagocytophilum. Treatment options are limited for this entity, with doxycycline being the drug of choice. Certain fluoroquinolones such as levofloxacin are active against A. phagocytophilum in vitro. We report a hospitalized patient with HGA who improved coincident with a 13-day course of levofloxacin therapy, but clinically and microbiologically relapsed 15 days after completion of treatment. Relapse of infection after levofloxacin therapy was reproduced in a severe combined immune-deficient (SCID) mouse infection model. Quinolone therapy should not be considered curative of HGA.


Subject(s)
Anaplasma phagocytophilum/drug effects , Anaplasmosis/drug therapy , Anti-Bacterial Agents/therapeutic use , Levofloxacin , Ofloxacin/therapeutic use , Aged , Anaplasma phagocytophilum/growth & development , Anaplasma phagocytophilum/pathogenicity , Anaplasmosis/blood , Anaplasmosis/pathology , Animals , Disease Models, Animal , Female , Humans , Male , Mice , Mice, SCID , Recurrence , Treatment Outcome
4.
Heart Lung ; 33(1): 61-4, 2004.
Article in English | MEDLINE | ID: mdl-14983142

ABSTRACT

We present a case of a 50-year-old man who presented to Winthrop-University Hospital in the midst of the 2002 West Nile encephalitis (WNE) outbreak with the cardinal clinical findings of WNE, ie, fever, encephalopathy, weakness, and muscle tremors. During the summer of 2002, several cases of aseptic meningitis/viral encephalitis were admitted to our emergency room weekly. In addition, cases of WNE were being admitted at the same time. During this period we had 3 cases of WNE. Our patient presented with the clinical findings of WNE. However, laboratory and radiologic findings suggested the possibility of Listeria monocytogenes encephalitis. The cerebrospinal fluid findings included red blood cells, which, in the absence of a traumatic tap or HSV encephalitis, argue against the diagnosis of WNE but are consistent with L. monocytogenes encephalitis. Computed tomography scan showed communicating hydrocephalus, which also suggests the possibility of L. monocytogenes and argued against the diagnosis of WNE. Clinicians should be vigilant for the mimics of WNE in geographical areas where WNE outbreaks are occurring.


Subject(s)
Encephalitis/diagnosis , Listeriosis/diagnosis , West Nile Fever/diagnosis , Diagnosis, Differential , Encephalitis/microbiology , Humans , Hydrocephalus/microbiology , Listeriosis/cerebrospinal fluid , Male , Middle Aged
SELECTION OF CITATIONS
SEARCH DETAIL
...